CME Group stock: Morgan Stanley lifts target to USD 359.00

Published on 10/23/2026 at 15:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Morgan Stanley kept Overweight and lifted its target to USD 359.00 on October 22, 2026. CME Group stock costs EUR 273.95 at Lang & Schwarz on October 23, 2026.

Analyst target raised

Morgan Stanley lifted its CME Group target from USD 337.00 to USD 359.00 on October 22, 2026.
The target stands 17.50 percent above CME Group's USD 305.42 Nasdaq price on October 23, 2026.
CME Group stock costs EUR 273.95 at Lang & Schwarz on October 23, 2026 at 3:35 p.m. CEST.

Bauhaus-inspiriertes geometrisches Poster mit FINANCE-Schriftzug und primären Farben — CME Group Inc. im Bauhaus-Posterdesign mit FINANCE-Text, ISIN US12572Q1058 geometrisch und farbenfroh gestaltet, Illustration mit AI erstellt.

CME Group Inc. (ISIN US12572Q1058) drew a higher USD 359.00 target from Morgan Stanley on October 22, 2026, up from USD 337.00. The research update gives investors a fresh valuation marker while the stock trades below that target in US dollars. CME Group was trading at EUR 273.95 at Lang & Schwarz on October 23, 2026 at 3:35 p.m. CEST.

Morgan Stanley widens the target gap

According to Markets Insider, Morgan Stanley analyst Michael Cyprys raised the target from USD 337.00 to USD 359.00 and kept an Overweight rating. Against CME Group's USD 305.42 Nasdaq price at 9:44 a.m. EDT on October 23, 2026, the new target implies 17.50 percent upside.

Price position carries the risk signal

CME Group's Nasdaq price was USD 305.42 on October 23, 2026 at 9:44 a.m. EDT, while the 52-week range was USD 218.31 to USD 329.16. The stock therefore stood 7.21 percent below its 52-week high, leaving the current quote closer to the upper end of its annual range than to the low.

The company had a market capitalization of USD 109.8 billion and a price-to-earnings ratio of 25.14 on October 23, 2026. Intercontinental Exchange traded at USD 163.72 with a price-to-earnings ratio of 23.18 and a market capitalization of USD 91.9 billion, while Nasdaq Inc. stood at USD 103.00 with a ratio of 28.46 and a market capitalization of USD 57.6 billion.

Recent earnings set the baseline

CME Group reported USD 1.74 billion in revenue for the third quarter of 2026, up 10.60 percent year over year, and adjusted earnings per share of USD 3.02 against a USD 2.99 consensus estimate, according to MarketBeat on October 22, 2026. The same report said quarterly revenue exceeded the USD 1.71 billion estimate, giving the analyst target revision a recent operating reference.

What the target means for valuation

The revised target is above the current Nasdaq price but remains below the USD 367.00 objective reported for JPMorgan's October 22 upgrade. That spread shows how widely analysts frame CME Group's value after the third-quarter report, even as the company operates a global futures and options marketplace.

Investor view

The key contrast is clear: CME Group's annual price range places the stock near its high, while Morgan Stanley's new target is higher still. The October 23, 2026 euro indication was EUR 273.95 at Lang & Schwarz, after the Xetra close.

The further course of trading is shown by the continuously updated real-time quote of CME Group stock.